Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01381029
What this trial is testing

Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals

Who this might be right for
Influenza, HumanHuman Immunodeficiency Virus I Infection
George Washington University 74
Testing effectiveness (Phase 2)Study completedNCT01704781
What this trial is testing

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

Who this might be right for
HIV-1 Infection
Bionor Immuno AS 36
Early research (Phase 1)Study completedNCT00001125
What this trial is testing

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

Who this might be right for
HIV InfectionsChickenpox
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00955006
What this trial is testing

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Ended earlyNCT00196651
What this trial is testing

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 60
Early research (Phase 1)Looking for participantsNCT06617091
What this trial is testing

A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.

Who this might be right for
HIV
International AIDS Vaccine Initiative 120
Early research (Phase 1)Study completedNCT00000846
What this trial is testing

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT04224701
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 48
Early research (Phase 1)Study completedNCT00083603
What this trial is testing

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Testing effectiveness (Phase 2)Study completedNCT02425241
What this trial is testing

Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination

Who this might be right for
HIV
University College, London 41
Not applicableActive Not RecruitingNCT06700447
What this trial is testing

Protecting Against HIV Vaccine Misinformation With Adolescent Girls and Young Women in South Africa

Who this might be right for
MisinformationHIV Vaccine
University of Pennsylvania 2,163
Post-approval studies (Phase 4)Study completedNCT01811823
What this trial is testing

Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults

Who this might be right for
InfluenzaHIVTuberculosis
University of Witwatersrand, South Africa 301
Testing effectiveness (Phase 2)Study completedNCT02741128
What this trial is testing

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Immunodeficiency Virus
Sanofi Pasteur, a Sanofi Company 133
Post-approval studies (Phase 4)Study completedNCT04754698
What this trial is testing

COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS

Who this might be right for
Rheumatic DiseaseHIV InfectionsAIDS+3 more
University of Sao Paulo General Hospital 2,196
Testing effectiveness (Phase 2)Study completedNCT03031912
What this trial is testing

African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola

Who this might be right for
Ebola
Canadian Immunization Research Network 251
Testing effectiveness (Phase 2)Study completedNCT00459316
What this trial is testing

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

Who this might be right for
HIV InfectionsMeningitis
National Institute of Allergy and Infectious Diseases (NIAID) 384
Testing effectiveness (Phase 2)Study completedNCT00976404
What this trial is testing

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

Who this might be right for
HIV Infection
Robert L. Murphy 28
Early research (Phase 1)Study completedNCT01378312
What this trial is testing

Evaluate Safety and Immunogenicity of AERAS-402

Who this might be right for
Tuberculosis
Aeras 12
Early research (Phase 1)Study completedNCT00124007
What this trial is testing

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Not applicableStudy completedNCT02077101
What this trial is testing

Representations and Acceptability of HIV Therapeutic Vaccine in a Cohort of HIV-1 Infected Outpatients Followed at Hospital

Who this might be right for
HIV
Hopital Foch 220
Next Page